Adverum Biotechnologies, Inc.
āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™

Adverum Biotechnologies Inc 🧙

Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and improve real-world vision outcomes for patients.

If you want not to miss ideas like this one,ðŸŽŊ subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! ðŸĪ“ Interested to study how to analyze charts, follow me!
ADVMbiotechnologyPivot PointsstocksignalsstockstradingSupply and DemandSupport and Resistancetradingasabusiness

āđāļĨāļ°āđƒāļ™:

āļ„āļģāļˆāļģāļāļąāļ”āļŠāļīāļ—āļ˜āļīāđŒāļ„āļ§āļēāļĄāļĢāļąāļšāļœāļīāļ”āļŠāļ­āļš